Trial of Rituximab, Bendamustine (RB) for Patients With Follicular Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line
This study is ongoing, but not recruiting participants.
Sponsor:
Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas
Information provided by (Responsible Party):
Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas
ClinicalTrials.gov Identifier:
NCT01127841
First received: March 18, 2010
Last updated: December 3, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |